Shubham leads McKinsey’s healthcare, public sector and social sector work globally. He serves leading healthcare and social institutions and governments on all top-management agenda issues. His primary areas of focus include strategy, growth, M&A, business building, and large-scale digital and performance transformations. In healthcare, he has extensively served publicly traded and not-for-profit payers as well as public payers for more than 20 years. He also serves providers as well as healthcare technology and pharmacy companies.
Shubham leads McKinsey’s COVID-19 response externally. He has worked alongside clients on immediate response efforts to save lives and livelihoods; developed strategies for companies to be resilient and pursue growth and new business building; supported preparations to resume economic growth and activity and return to the workplace; and advised on navigating the imminent restructuring of the global economic order.
He also leads the firm’s thinking and research on the future of healthcare in the wake of rapid advancements in digital, advanced analytics, and medical technologies; emergence of new treatments; healthcare reform and regulatory change; the rise of the healthcare consumer; and risk disaggregation and reallocation across the healthcare system. He has deeply studied the shifts in overall spend as well as profit pools within the healthcare industry as these structural shifts play out. His expertise has been key in defining the structural and performance implications of this transformation for payers, providers, and services organizations across the healthcare value chain.
Shubham has led the significant expansion of the firm's capabilities in the development deep technical expertise in areas like advanced analytics, actuarial, implementation, design and digital. He has championed the development and growth of the McKinsey Center for US Health System Reform and the Center for Societal Benefit through Healthcare to advance our aspiration to fundamentally improve healthcare.
Published work
“The next frontier of care delivery in healthcare,” McKinsey & Company, March 2022
“When will the COVID-19 pandemic end?,” McKinsey & Company, March 2022
“Consumer prices are rising fast, and healthcare isn’t far behind,” McKinsey & Company, February 2022
“New variant, new challenges: How are we coping with Omicron?,” McKinsey & Company, February 2022
“When will the COVID-19 pandemic end?,” McKinsey & Company, December 2021
“Pandemic to endemic: How the world can learn to live with COVID-19,” McKinsey & Company, October 2021
“Innovating employee health: Time to break the mold?,” McKinsey & Company, September 2021
“When will the COVID-19 pandemic end?,” McKinsey & Company, August 2021
“A light at the end of the tunnel: US COVID-19 vaccine administration,” McKinsey & Company, April 2021
“Leap to the future of healthcare: Reinvent through business building,” McKinsey & Company, April 2021
“The risks and challenges of the global COVID-19-vaccine rollout,” McKinsey & Company, January 2021
“The next normal arrives: Trends that will define 2021—and beyond,” McKinsey & Company, January 2021
“What now? Decisive actions to emerge stronger in the next normal,” McKinsey & Company, September 2020
“The great acceleration in healthcare: Six trends to heed,” McKinsey & Company, September 2020
“An optimistic scenario for the US response to COVID-19,” McKinsey & Company, September 2020
“COVID-19: Saving thousands of lives and trillions in livelihoods,” McKinsey & Company, August 2020
“‘And now win the peace’: Ten lessons from history for the next normal,” McKinsey & Company, July 2020
“Ten innovations that can improve global health,” McKinsey & Company, July 2020
“How prioritizing health could help rebuild economies,” McKinsey & Company, July 2020
“Reopening safely: Sample practices from essential businesses,” McKinsey & Company, May 2020
“From thinking about the next normal to making it work: What to stop, start, and accelerate,” McKinsey & Company, May 2020
“COVID-19: Strategies for getting ahead of the pandemic crisis,” McKinsey & Company, April 2020
“The future is not what it used to be: Thoughts on the shape of the next normal,” McKinsey & Company, April 2020
“Critical care capacity: The number to watch during the battle of COVID-19,” McKinsey & Company, March 2020
“Beyond coronavirus: The path to the next normal,” McKinsey & Company, March 2020
Future of Healthcare
“The future of healthcare: Value creation through next-generation business models,” McKinsey & Company, January 2021
“Fit for the future: The common challenges facing healthcare systems—and how to meet them,” McKinsey & Company, October 2019
“Recession and resilience: Preparing healthcare leaders for the next economic downturn,” McKinsey & Company, July 2019
“The era of exponential improvement in healthcare?,” McKinsey & Company, May 2019
“The future of healthcare: Finding the opportunities that lie beneath the uncertainty,” McKinsey & Company, January 2018
“Why the evolving healthcare services and technology market matters,” McKinsey & Company, May 2018
“Planning for the future of healthcare – Benjamin Breier, President and CEO, Kindred Healthcare,” McKinsey & Company, December 2017
Productivity and Growth
“The productivity imperative for healthcare delivery in the United States,” McKinsey & Company, February 2019
“Trends disrupting pharmacy value pools and potential implications for the value chain,” McKinsey & Company, February 2018
“Where to compete in today’s healthcare market,” McKinsey & Company, May 2017
“Value-based care: is it sustainable?” McKinsey & Company, May 2017
“The growth opportunity for private health insurance companies,” McKinsey & Company, January 2017
“Payors in Care Delivery: When Does Vertical Integration Make Sense?” Health Affairs, February 2014
Past Experience
Unilever
Various executive positions, including plant and engineering management
Education
Carnegie Mellon University
MBA
Indian Institute of Technology, Bombay
BSc, mechanical engineering